
    
      This is a prospective, multi-center, observational study. The research will be performed in
      three phases, each using distinct patient cohorts:

      Phase I: Discovery - genes/biomarkers/clinical factors Phase II: Algorithm Development Phase
      III: Assay Validation

      The final algorithm (Assay) may incorporate a combination of factors including genetic
      markers, biomarker(s), and clinical factor(s). Participation in the study does not alter
      clinical care. The procedures required by the protocol are collection of a research blood
      sample (at baseline only) and interviews with the subject to collect specific clinical
      information at baseline and follow-up (6 mos, 1 yr, 2 yr, 3 yr, 4 yr, and 5 yr) after
      enrollment. All other data collected is in accordance with the participating institution's
      standard patient care.
    
  